Skip to main content

Thermo Fisher Scientific company profile

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides products and services for science, healthcare and industry through five reporting segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. Its offerings include reagents, instruments and consumables for biological research and bioproduction, analytical instruments such as chromatography, mass spectrometry and electron microscopy, diagnostic test kits and culture media, laboratory consumables and chemicals, and outsourced pharma development, manufacturing and clinical research services. Customers include pharmaceutical and biotechnology companies, hospitals and clinical laboratories, universities, research institutions and government agencies. The company sells through a direct sales force, electronic commerce and third-party distributors and operates globally, with colleagues in the Americas, Asia-Pacific, and Europe, the Middle East and Africa.

A summary of the business section of the company's latest annual report, filed 26 Feb 2026.

Company facts

TickerTMO · NYSE
SectorInstruments
IndustryLife Sciences Tools & Services
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK97745
Latest annual report10-K, filed 26 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Marc N. CasperChairman & CEO · Director450K · < 1%Shares withheld for tax, 28 Aug 2026
Michel LagardeExecutive Vice President170K · < 1%Shares withheld for tax, 28 Feb 2026
Stephen WilliamsonRetiring Sr. VP and CFO145K · < 1%Shares withheld for tax, 28 Feb 2026
Frederick M. LoweryExecutive Vice President102K · < 1%Shares withheld for tax, 28 Feb 2026
Gianluca PettitiPresident & COO92.5K · < 1%Sale under a 10b5-1 plan, 31 Aug 2026
Scott M. SperlingDirector68.4K · < 1%Gift, 28 Oct 2026
Nelson J. ChaiDirector14.3K · < 1%Grant or award, 20 May 2026
C. Martin HarrisDirector8.5K · < 1%Grant or award, 20 May 2026
Tyler JacksDirector8.4K · < 1%Grant or award, 20 May 2026
Dion J. WeislerDirector4.5K · < 1%Shares withheld for tax, 20 May 2026
James C. MullenDirector2.8K · < 1%Grant or award, 21 May 2025
Ruby R. ChandyDirector2.4K · < 1%Grant or award, 20 May 2026
Debora L. SparDirector1.5K · < 1%Grant or award, 20 May 2026
R. Alexandra KeithDirector1.5K · < 1%Grant or award, 20 May 2026
Jennifer M. JohnsonDirector339 · < 1%Grant or award, 20 May 2026
Karen S. LynchDirector171 · < 1%Grant or award, 20 May 2026
Britt Lisa P.Sr. VP and Chief HR Officer—Open-market sale, 28 Oct 2026
Meyer JamesSr. Vice President & CFO—Shares withheld for tax, 28 Aug 2026
Shropshire Thomas B Jr.SVP and General Counsel—Shares withheld for tax, 28 Aug 2026
Shafer Michael DExecutive Vice President—Shares withheld for tax, 28 Aug 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

TMO in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.